A certificate of analysis that reads “glutathione content: 98.0% (HPLC)” looks like a definitive statement. In practice, it isn’t. The number is accurate given the method used to produce it, but “HPLC” is not a single method — it’s a family of analytical techniques, and the specific conditions under which the test is run affect the result. Two laboratories testing the same batch of reduced glutathione powder using HPLC can return results that differ by several percentage points, both reporting accurately against their respective methods.
This matters for buyers comparing supplier certificates, for formulators setting raw material specifications, and for quality teams deciding how much incoming inspection to perform on each batch.
What HPLC measures and how it works
High-performance liquid chromatography separates the components of a sample by passing it through a column packed with a stationary phase material, using a solvent (the mobile phase) to carry the sample through. Different compounds interact differently with the stationary phase — some move through quickly, some slowly — and this difference in retention time allows the instrument to separate and detect individual components.
For glutathione, the detector typically used is UV absorbance at 210–215nm, where the peptide bond and thiol group absorb ultraviolet light. The area under the peak at glutathione’s retention time is proportional to the amount of glutathione present, calculated against a reference standard of known concentration.
The purity percentage reported is the ratio of the glutathione peak area to the total integrated area of all detected peaks — not necessarily all components present, but all components that the specific method detects under those conditions.
Why the same sample can give different results at different labs
The specific conditions of the HPLC method determine what gets separated, what gets detected, and how peak areas are assigned. The variables include:
Column chemistry: C18 reverse-phase columns are most common for glutathione analysis, but different C18 columns from different manufacturers have different surface chemistries, which affects how well glutathione separates from adjacent peaks. A column with lower selectivity for the glutathione-GSSG separation may co-elute these two compounds partially, inflating the glutathione peak area.
Mobile phase composition and pH: Glutathione’s retention and peak shape are sensitive to mobile phase pH and the presence of ion-pairing agents. Trifluoroacetic acid (TFA) is commonly used as a mobile phase modifier; the concentration affects retention time and peak shape. Methods with different TFA concentrations or different buffer systems will produce different chromatographic profiles from the same sample.
Gradient vs. isocratic elution: Some methods run with a constant mobile phase composition (isocratic); others change the composition over time (gradient). The method type affects how well impurities are resolved from the main peak.
Reference standard quality: The purity of the reference standard used to calibrate the quantitation affects the reported result directly. A reference standard that is itself 97% pure, used without correction, will underestimate the sample’s true purity by approximately 3%.
Sample preparation: Glutathione oxidizes readily in solution. A sample prepared 30 minutes before injection in ambient conditions will have converted some GSH to GSSG compared to a sample prepared immediately before injection under inert atmosphere. The sample preparation protocol affects the GSH/GSSG ratio measured.
The GSSG problem
Reduced glutathione (GSH) and oxidized glutathione (GSSG) are structurally related compounds that elute at different retention times under most HPLC conditions. A method that adequately separates GSH from GSSG counts only the GSH peak in the “glutathione content” determination. A method with poor resolution may include part of the GSSG peak in the GSH area, overstating the GSH content.
This matters because GSSG is present in all commercial reduced glutathione powder at some level — typically a few percent in a well-stored, high-quality batch, higher in aged or poorly stored material. The relationship between reported purity and the actual GSH/GSSG ratio depends entirely on how well the method resolves these two compounds.
Pharmacopeial methods as a reference point
Chinese Pharmacopoeia (ChP) and Japanese Pharmacopoeia (JP) both include monographs for reduced glutathione with specified HPLC methods. These methods define the column type, mobile phase, gradient conditions, reference standard, and acceptance criteria. Results obtained using the pharmacopeial method are directly comparable between laboratories — because both labs are following the same protocol.
Results obtained using a “house method” (a lab’s internally developed HPLC method) are comparable only within that lab’s system. When a supplier’s CoA says “HPLC” without specifying the method standard, it may mean the pharmacopeial method or it may mean their own internal method. The distinction is meaningful when comparing certificates from different suppliers.
For procurement specifications, requesting that the CoA explicitly state compliance with ChP or JP reduces ambiguity. A supplier who cannot provide a pharmacopeial-method result for reduced glutathione powder may not have the laboratory capability to run it, or may have house method results that would differ from pharmacopeial results.
What a 98% result actually guarantees
Even with a fully specified pharmacopeial method, a 98% result means:
- At least 98% of the detected chromatographic area corresponds to the glutathione peak, under those conditions
- Impurities that don’t absorb UV at the detection wavelength (UV-transparent compounds) are not counted — they don’t appear as peaks and don’t reduce the reported purity
- Inorganic contaminants (heavy metals, ash) are not measured by HPLC — those require separate methods (AAS for metals, loss on ignition for ash)
- Moisture content is not captured — a dry-weight basis correction may or may not have been applied
A complete quality picture for reduced glutathione powder requires the HPLC purity result plus complementary tests: Karl Fischer titration for water content, heavy metals testing (particularly arsenic and lead), residual solvent analysis if synthesis involves organic solvents, and microbiological limits for grades destined for oral or topical applications.
A supplier CoA that shows only HPLC purity is providing partial information. A complete CoA that shows purity, water content, heavy metals, and bioburden against a stated pharmacopeial reference is a more reliable basis for incoming material release.
Practical implications for incoming inspection
For buyers receiving reduced glutathione powder on a supplier relationship where the method and reference standard are established and consistent, a high HPLC purity result on each batch CoA provides meaningful batch-to-batch consistency information. The absolute value depends on the method; the consistency across batches is the signal.
For buyers evaluating a new supplier or comparing multiple suppliers, asking for the method standard (pharmacopeial reference number), the reference standard source and lot certificate, and the sample preparation protocol gives enough information to assess whether the results are directly comparable to what you’re currently receiving. If they aren’t — different method, different reference standard — independent third-party testing on matched samples from both suppliers using a common method is the most reliable comparison.
The 98% on the CoA is the start of the quality conversation, not the end of it.
